Conditional Antibody Design as 3D Equivariant Graph Translation
- URL: http://arxiv.org/abs/2208.06073v6
- Date: Thu, 30 Mar 2023 12:30:46 GMT
- Title: Conditional Antibody Design as 3D Equivariant Graph Translation
- Authors: Xiangzhe Kong, Wenbing Huang, Yang Liu
- Abstract summary: We propose Multi-channel Equivariant Attention Network (MEAN) to co-design 1D sequences and 3D structures of CDRs.
Our method significantly surpasses state-of-the-art models in sequence and structure modeling, antigen-binding CDR design, and binding affinity optimization.
- Score: 28.199522831859998
- License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
- Abstract: Antibody design is valuable for therapeutic usage and biological research.
Existing deep-learning-based methods encounter several key issues: 1)
incomplete context for Complementarity-Determining Regions (CDRs) generation;
2) incapability of capturing the entire 3D geometry of the input structure; 3)
inefficient prediction of the CDR sequences in an autoregressive manner. In
this paper, we propose Multi-channel Equivariant Attention Network (MEAN) to
co-design 1D sequences and 3D structures of CDRs. To be specific, MEAN
formulates antibody design as a conditional graph translation problem by
importing extra components including the target antigen and the light chain of
the antibody. Then, MEAN resorts to E(3)-equivariant message passing along with
a proposed attention mechanism to better capture the geometrical correlation
between different components. Finally, it outputs both the 1D sequences and 3D
structure via a multi-round progressive full-shot scheme, which enjoys more
efficiency and precision against previous autoregressive approaches. Our method
significantly surpasses state-of-the-art models in sequence and structure
modeling, antigen-binding CDR design, and binding affinity optimization.
Specifically, the relative improvement to baselines is about 23% in
antigen-binding CDR design and 34% for affinity optimization.
Related papers
- AntibodyFlow: Normalizing Flow Model for Designing Antibody Complementarity-Determining Regions [9.427196604657215]
Therapeutic antibodies are specialized protective proteins that bind to antigens in a lock-to-key manner.
The binding strength/affinity between an antibody and a specific antigen is heavily determined by the complementarity-determining regions (CDRs) on the antibodies.
Existing machine learning methods cast in silico development of CDRs as either sequence or 3D graph (with a single chain) generation tasks.
arXiv Detail & Related papers (2024-06-19T02:31:23Z) - Antigen-Specific Antibody Design via Direct Energy-based Preference Optimization [51.28231365213679]
We tackle antigen-specific antibody sequence-structure co-design as an optimization problem towards specific preferences.
We propose direct energy-based preference optimization to guide the generation of antibodies with both rational structures and considerable binding affinities to given antigens.
arXiv Detail & Related papers (2024-03-25T09:41:49Z) - A Hierarchical Training Paradigm for Antibody Structure-sequence
Co-design [54.30457372514873]
We propose a hierarchical training paradigm (HTP) for the antibody sequence-structure co-design.
HTP consists of four levels of training stages, each corresponding to a specific protein modality.
Empirical experiments show that HTP sets the new state-of-the-art performance in the co-design problem.
arXiv Detail & Related papers (2023-10-30T02:39:15Z) - Cross-Gate MLP with Protein Complex Invariant Embedding is A One-Shot
Antibody Designer [58.97153056120193]
The specificity of an antibody is determined by its complementarity-determining regions (CDRs)
Previous studies have utilized complex techniques to generate CDRs, but they suffer from inadequate geometric modeling.
We propose a textitsimple yet effective model that can co-design 1D sequences and 3D structures of CDRs in a one-shot manner.
arXiv Detail & Related papers (2023-04-21T13:24:26Z) - End-to-End Full-Atom Antibody Design [28.199522831859998]
There are two major defects in current learning-based methods, making them suboptimal or resource-intensive.
We propose dynamic Multi-channel Equivariant grAph Network (dyMEAN), an end-to-end full-atom model for E(3) antibody design.
Both 1D sequences and 3D structures are updated via an adaptive multi-channel encoder that is able to process protein residues of variable sizes when considering full atoms.
Experiments on CDR-H3 design, complex structure prediction, and affinity optimization demonstrate the superiority of our end-to-end framework and full-atom modeling.
arXiv Detail & Related papers (2023-02-01T03:13:19Z) - xTrimoABFold: De novo Antibody Structure Prediction without MSA [77.47606749555686]
We develop a novel model named xTrimoABFold to predict antibody structure from antibody sequence.
The model was trained end-to-end on the antibody structures in PDB by minimizing the ensemble loss of domain-specific focal loss on CDR and the frame-aligned point loss.
arXiv Detail & Related papers (2022-11-30T09:26:08Z) - Incorporating Pre-training Paradigm for Antibody Sequence-Structure
Co-design [134.65287929316673]
Deep learning-based computational antibody design has attracted popular attention since it automatically mines the antibody patterns from data that could be complementary to human experiences.
The computational methods heavily rely on high-quality antibody structure data, which is quite limited.
Fortunately, there exists a large amount of sequence data of antibodies that can help model the CDR and alleviate the reliance on structure data.
arXiv Detail & Related papers (2022-10-26T15:31:36Z) - Reprogramming Pretrained Language Models for Antibody Sequence Infilling [72.13295049594585]
Computational design of antibodies involves generating novel and diverse sequences, while maintaining structural consistency.
Recent deep learning models have shown impressive results, however the limited number of known antibody sequence/structure pairs frequently leads to degraded performance.
In our work we address this challenge by leveraging Model Reprogramming (MR), which repurposes pretrained models on a source language to adapt to the tasks that are in a different language and have scarce data.
arXiv Detail & Related papers (2022-10-05T20:44:55Z) - Simple End-to-end Deep Learning Model for CDR-H3 Loop Structure
Prediction [0.0]
We present an end-to-end model to predict CDR H3 loop structure, that performs on par with state-of-the-art methods.
We also raise an issue with a commonly used RosettaAntibody benchmark that leads to data leaks.
arXiv Detail & Related papers (2021-11-20T18:55:09Z) - Iterative Refinement Graph Neural Network for Antibody
Sequence-Structure Co-design [35.215029426177004]
We propose a generative model to automatically design antibodies with enhanced binding specificity or neutralization capabilities.
Our method achieves superior log-likelihood on the test set and outperforms previous baselines in designing antibodies capable of neutralizing the SARS-CoV-2 virus.
arXiv Detail & Related papers (2021-10-09T18:23:32Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.